Price $133.44 |
Market Cap
26.36B
|
Sector Health Care |
Div. Growth
16.10%
|
|
P/E
-
|
P/B
2.85
|
P/S
0.13
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
16.6
|
Op. Cash Flow
2.54M
|
FCF
8.0
|
|
Op. Margin
-
|
Net Margin
-0.20%
|
ROE
-3.60%
|
ROI
-1.00%
|
|
ROA
-0.60%
|
EPS Growth
-108.40%
|
Current Ratio
1.0
|
Debt/Equity
68.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Imprimis Pharmaceuticals Inc (IMMY) | $3.48 | - | - | 58.7M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.40 | - | - | 37.2M | Strong Buy |
| Vaxart Inc (VXRT) | $3.20 | - | - | 20.3M | Strong Buy |
| Procyon Corp (PCYN) | $0.29 | - | - | 2.3M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.50 | - | - | 91.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
